bioRxiv ScienceSearch

bioRxiv · 10.1101/800656

Partner-specific induction of Spodoptera frugiperda immune genes in response to the entomopathogenic nematobacterial complex Steinernema carpocapsae-Xenorhabdus nematophila

Abstract

The Steinernema carpocapsae-Xenorhabdus nematophila association is a nematobacterial complex (NBC) used in biological control of insect crop pests. The ability of this dual pathogen to infest and kill an insect strongly depends on the dialogue between the hosts immune system and each partner of the complex. Even though this dialogue has been extensively studied from the two partners points of view in several insect models, still little is known about the structure and the molecular aspects of the insects immune response to the dual infection. Here, we used the lepidopteran pest Spodoptera frugiperda as a model to analyze the respective impact of each NBC partner in the spatiotemporal immune responses that are induced after infestation. To this aim, we first analyzed the expression variations of the insects immune genes in the fat bodies and hemocytes of infested larvae by using previously obtained RNAseq data. We then selected representative immune genes for RT-qPCR investigations of the temporal variations of their expressions after infestation and of their induction levels after independent injections of each partner. We found that the fat body and the hemocytes both produce potent and stable immune responses to the infestation by the NBC, which correspond to combinations of bacterium- and nematode-induced ones. Consistent with the nature of each pathogen, we showed that X. nematophila mainly induces genes classically involved in antibacterial responses, whereas S. carpocapsae is responsible for the induction of lectins and of genes expected to be involved in melanization and cellular encapsulation. In addition, we found that two clusters of unknown genes dramatically induced by the NBC also present partner-specific induction profiles, which paves the way for their functional characterization. Finally, we discuss putative relationships between the variations of the expression of some immune genes and the NBCs immunosuppressive strategies.\n\nAuthor summaryEntomopathogenic nematodes (EPNs) are living in the soil and prey upon insect larvae. They enter the insect by the natural orifices, and reach the hemocoel through the intestinal epithelium. There, they release their symbiotic bacteria that will develop within the insect and eventually kill it. Nematodes can then feed and reproduce on the insect cadaver. By using transcriptomic approaches, we previously showed that Lepidoptera larvae (caterpillars of the fall armyworm Spodoptera frugiperda) produce a strong immune response in reaction to infestation by EPNs. However, we do not know if this immune reaction is triggered by the nematode itself -Steinernema carpacapsae - or its symbiotic bacteria - Xenorhabdus nematophila. To answer this question, we present in this work a careful annotation of immunity genes in S. frugiperda and surveyed their activation by quantitative PCR in reaction to an injection of the bacteria alone, the axenic nematode or the associated complex. We found that the immune genes are selectively activated by either the bacteria or the nematode and we discuss the implication of which pathway are involved in the defense against various pathogens. We also show that a cluster of newly discovered genes, present only in Lepidoptera, is activated by the nematode only and could represent nematicide genes.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Huot, L., Bigourdan, A., Pages, S., Ogier, J.-C., Girard, P.-A., Negre, N., Duvic, B.. 2019-10-10. Partner-specific induction of Spodoptera frugiperda immune genes in response to the entomopathogenic nematobacterial complex Steinernema carpocapsae-Xenorhabdus nematophila. https://doi.org/10.1101/800656

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

De novo design of CR2 binder as vaccine scaffold

Efficient B cell activation during vaccine-induced humoral immunity relies on both B cell receptor (BCR) antigen recognition and synergistic signaling from co-receptors. Complement receptor 2 (CR2), the primary BCR co-receptor on B cells, lowers the activation threshold and amplifies downstream kinase signaling by orders of magnitude when engaged by complement fragment C3d decorated antigens. Targeting CR2 therefore represents a rational vaccine enhancement strategy, yet native C3d suffers from low affinity, poor stability, and manufacturing challenges. Here, we report the de novo design of a highly stable, high-affinity CR2 binder using deep learning driving protein design methods. Biophysical characterization, high-resolution cryoEM structural determination, and functional assays in vitro and in vivo confirm that the designed binder matches computational design models and specifically engages CR2 to boost B cell activation. When fused to antigen as a vaccine scaffold, the trimeric CR2 binder elicits robust humoral immune responses comparable to nanoparticle vaccines, while retaining the simplicity of single-chain protein production. Our work establishes a modular CR2 targeting vaccine scaffold platform with broad translational potential for next-generation protein vaccines.

immunology

Chronic opioid-associated immune dysregulation among people living with HIV

Objectives: Persistent immune dysregulation contributes to chronic disease among people living with HIV (PWH), even after viral suppression with antiretroviral therapy (ART). Although chronic opioid exposure is associated with adverse clinical outcomes, its impact on immune homeostasis during ART remains incompletely understood. We investigated whether opioid use disorder (OUD) is associated with persistent systemic and cellular immune dysregulation despite ART-mediated reductions in HIV viral load (VL). Methods: Peripheral blood was collected longitudinally from PWH with OUD (PWH/OUD+) and detectable HIV VL during 6 months of optimized ART (months 0, 3, and 6). A reference cohort of PWH without OUD (PWH/OUD-) and suppressed HIV VL provided a single blood sample. Immune profiling included plasma inflammatory biomarkers, multiplex cytokine analyses, spectral flow cytometry, and assessment of monocyte cytokine responses following lipopolysaccharide (LPS) stimulation. Mixed-effects models adjusted for HIV VL and VL-stratified analyses were performed. Results: PWH/OUD+ exhibited persistent immune dysregulation despite reductions in HIV VL. Plasma sCD163, sCD14, fractalkine, and I-TAC remained elevated, whereas TGF-{beta}1 was reduced. OUD was associated with expansion of CD16 monocytes and altered expression of CCR2, CD38, and CD11b. CD4 and CD8 T cells, NK cells, and B cells also exhibited persistent alterations in markers of activation, metabolism, and trafficking. Monocytes from PWH/OUD+ displayed attenuated cytokine responses following LPS stimulation. Conclusions: OUD is associated with persistent systemic and cellular immune dysfunction in PWH despite ART-mediated viral suppression, supporting opioid exposure as an independent contributor to chronic immune dysregulation that may promote inflammation, immune dysfunction, and long-term HIV-associated comorbidities. Keywords: HIV, Opioid-use disorder, innate immunity, cytokine

immunology

The mitochondrial RNA extrusion-induced innate immunity is regulated by N6-methyladenosine machinery

Mitochondrial RNA (mtRNA) released into the cytosol functions as a damage associated molecular pattern that activates pattern-recognition receptor (PRR)-mediated inflammation, yet its release mechanisms and cytoplasmic fate remain poorly understood. Here we report that chemical Abt-373-treatment and Vesicular stomatitis virus (VSV) infection induce mtRNA extrusion through Bax/Bak and VDAC1 channels, accompanied by mtDNA release. Extruded mtRNA in A549 cells activates multiple cytosolic PRRs, including RIG-I, MDA5, TLR3/7/8, and PKR, each contributing differentially to the innate immune signaling. Analysis of GEO datasets and methylated RNA immunoprecipitation (MeRIP) assays further reveals that mtRNA carries methyladenosine (m6A) modification. m6A machinery proteins are involved in the cytoplasmic retention time of mtRNA and its interaction with RIG-I, thereby modulating mtRNA-induced innate immunity. Thus, our work establishes in vitro models of mtRNA extrusion, and highlights m6A-dependent modulation as a potential therapeutic target for mtRNA-driven inflammation.

immunology